INS and type 2 diabetes mellitus: Peripheral blockade of DR could therefore result in increased insulin release and sensitivity, thus promoting adipogenesis, weight gain, insulin resistance, and ultimately type 2 diabetes [21], adverse metabolic effects also described for neuroleptics [37].